We are live on
!
Find out more
AC
Aperimus Capital Portfolio holdings
AUM
$62.2M
1-Year Est. Return
47.35%
This Fund
S&P 500
This Quarter
Est. Return
-26.15%
1 Year Est. Return
+47.35%
3 Year Est. Return
+43.98%
5 Year Est. Return
+93.69%
10 Year Est. Return
–
AUM
$154M
AUM Growth
-$40.8M
(-21%)
Cap. Flow
+$14.9M
Cap. Flow
% of AUM
9.67%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
2
Increased
2
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$7.26M |
| 2 |
Cintas
CTAS
|
+$5.75M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$3.32M |
| 4 |
VAPO
Vapotherm, Inc. Common Stock
VAPO
|
+$1.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 2.48% |
| 2 | Healthcare | 1.17% |
Similar funds
QVT
RC
HCMT
DHRFI
WCM
BCM
TG
CCM
Aperimus Capital's Q1 2020 Portfolio in Review
As of Q1 2020, Aperimus Capital held 5 positions worth $154M, down 21% from $195M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Aperimus Capital deployed $14.9M of net new capital in Q1 2020, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was Cintas: 88,000 shares worth $3.81M.
By sector, the portfolio is most concentrated in Industrials at 2.5% of assets, followed by Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.53M trimmed.
- Aperimus Capital's largest Q1 2020 buy was Cintas: 88,000 shares worth $3.81M.
- Aperimus Capital added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q1 2020, an estimated $7.26M increase.
- Aperimus Capital's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.53M.
- Aperimus Capital's ten largest holdings make up 100% of its $154M portfolio in Q1 2020.
- Aperimus Capital opened 2 new positions and closed 0 in Q1 2020.
- Aperimus Capital's portfolio value fell 21% quarter-over-quarter to $154M.
Based on Aperimus Capital's 13F filing for Q1 2020, filed 1 May 2020.